Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)

The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision NOSI. Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this FOA.

Funding Opportunity Details

Full Announcement: PA-20-163
Related Notices or Announcements: NOT-OD-23-101; NOT-OD-23-012; NOT-OD-22-190; NOT-OD-22-018; NOT-OD-21-181; NOT-OD-21-169; NOT-OD-21-170; NOT-OD-21-109; NOT-HL-20-795; NOT-DK-20-012

Program Contact: Contact the Program Officer listed on NoA of the most recent parent award.

Activities: See the Full Announcement for the list of all related Activities.

NOTE: The NIDDK does not co-sponsor the NIH Exploratory Developmental Research Grant Program (Parent R21). The NIDDK will continue to accept R21 applications submitted in response to targeted NIDDK solicitations.

Key Dates

Open Date: 3/17/2022

Letter of Intent Due Date: Not Applicable

Application Due Date:

See the competitive revision NOSI for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.